Cargando…
Paclitaxel induces apoptosis through the TAK1–JNK activation pathway
Paclitaxel (PTX) has previously been used to treat tumours of various tissue origins, such as lung, breast, ovarian, prostate cancers and leukemia. PTX‐induced apoptosis is associated with p38 mitogen‐activated protein kinase (p38 MAPK), extracellular signal‐regulated kinase (ERK), nuclear factor‐ka...
Autores principales: | Yu‐Wei, Di, Li, Zhuo‐sheng, Xiong, Shu‐min, Huang, Ge, Luo, Yan‐fei, Huo, Tie‐ying, Zhou, Mao‐hua, Zheng, You‐wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396445/ https://www.ncbi.nlm.nih.gov/pubmed/32594651 http://dx.doi.org/10.1002/2211-5463.12917 |
Ejemplares similares
-
Excessive Dpp signaling induces cardial apoptosis through dTAK1 and dJNK during late embryogenesis of Drosophila
por: Yang, Sheng-An, et al.
Publicado: (2011) -
Inhibition of TNF-α and JNK Signaling Pathway Can Reduce Paclitaxel-Induced Apoptosis of Mouse Cardiomyocytes
por: Ren, Shuang, et al.
Publicado: (2022) -
SHP‐1 suppresses endotoxin‐induced uveitis by inhibiting the TAK1/JNK pathway
por: Zhuang, Xiaonan, et al.
Publicado: (2020) -
Arginyltransferase knockdown attenuates cardiac hypertrophy and fibrosis through TAK1-JNK1/2 pathway
por: Singh, Kanika, et al.
Publicado: (2020) -
Tomoregulin-1 prevents cardiac hypertrophy after pressure overload in mice by inhibiting TAK1-JNK pathways
por: Bao, Dan, et al.
Publicado: (2015)